Overview: Creatine Kinase (CK) TestIntroduction: The Creatine Kinase Test measures creatine kinase to diagnose muscle damage or heart attack, causing muscle pain or chest pain. Aligned with 2023 AHA guidelines, it uses spectrophotometry for high sensitivity, aiding in metabolic screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in biochemistry for patients with suspected muscle or heart disorders.
Other Names: CK Assay, Muscle Enzyme Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Creatine kinase testing began in the 1960s with muscle and heart research. Spectrophotometry emerged in the 1970s, and by the 2000s, automated analyzers improved accuracy.
Purpose: Diagnoses muscle damage or heart attack, guides treatment, and monitors CK levels in patients with muscle pain or chest pain.
Test Parameters: 1. Creatine Kinase
Pretest Condition: Fasting for 10-12 hours required to stabilize CK levels. Collect serum or plasma after overnight fasting. Report symptoms like muscle pain or chest pain, and list medications like statins.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document muscle pain, chest pain, or history of heart disease. Include current medications, especially statins or muscle relaxants.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for cardiac or muscle treatment.
Procedural Considerations: Uses spectrophotometry to measure CK levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting samples, exercise, or statins may elevate CK levels. Hemolysis or improper storage can degrade samples.
Clinical Significance: Elevated CK levels indicate muscle damage or heart attack, prompting treatment. Normal levels suggest alternative diagnoses.
Specialist Consultation: Consult a cardiologist for heart-related results or a neurologist for muscle-related issues.
Additional Supporting Tests: CK-MB test, troponin test, or EMG to confirm heart attack or muscle damage.
Test Limitations: False positives may occur with exercise or trauma. Results require clinical correlation.
References: AHA Cardiac Guidelines, 2023; Circulation, Thygesen K, 2022.
